SUMMARY
Main research interests: Genomics of Addictions, Psychiatric Pharmacogenomics, Prediction of the treatment outcome.
Research Protocols:
Active:
MPDZ polymorphisms and severe alcohol withdrawal.
Role: Principal Investigator
Evaluation of Predictive Value of Heart Rate Variability (HRV) in Treatment of Depression with Electroconvulsive Therapy.
Role: Principal Investigator
Pharmacogenomics of Phase II Drug Metabolizing Enzymes (PGRN II)- SSRI Pharmacogenomic Project.
Role: Co-Investigator
Treatment Outcomes in Patients Prescribed Acamprosate in Residing and Outpatient Settings: A Chart Review.
Role: Co-Investigator
Developing a DNA Repository for Genomic Studies of Addiction: A Pilot Study.
Role: Co-Investigator
Completed:
Evaluation of Genetic Differences in Alcoholics with Severe Withdrawal: A Pilot Study.
Role: Principal Investigator
Effect of Electroconvulsive Therapy on Heart Rate Variability: A Pilot Study.
Role: Principal Investigator